Closed transaction

ASSORT PTY LTD (Australia). Software created by world-leading ophthalmologist Professor Noel Alpins for calculating optimum measurements used in vision correction surgery, such as LASIK.

Advised by
Client
ASSORT PTY LTD
Deal stage
Closed transaction
Service
Sell
Sector
Healthcare
Sub-sector
Medical Devices
Market
Asia
Contact
lindley.edwards@afgventuregroup.com

Deal details

ASSORT Pty Ltd is an Australian private company which 100% owns the Assort intellectual property. Assort IP is software and know-how that deals with vision problems, specifically farsightedness, nearsightedness and astigmatism. Assort IP has been developed by Professor Alpins who is a world renowned authority, and has developed a method for predicting the surgical measurements required in vision correction surgery (such as LASIK). The techniques are known and recognised by international medical journals as The Alpins Method.

Lindley Edwards RolePartner FirmAFG Venture Group Lindley Edwards is a specialist adviser in merger, acquisition, divestments, fund raising, strategic consulting and licensing for growth public and private companies. View profile

AFG Venture Group latest deals

Equity advisory

Setmetrics provides engineering grade modelling tool to allow commercial and industrial built environment owners to improve facility and energy management efficiency.

Where
Australia
Year
2023
Equity advisory

Raise Pre IPO $1.2 Million capital for a sustainable Electric Vehicle Charging Stations company, which is aggregating carwash business and adding rapid charging capacity.

Where
Australia
Year
2023
Equity advisory

Raise AUD $1Million: AI coaching for professional & personal development platform for individuals & teams.

Where
Australia
Year
2023
Equity advisory

Raising convertible notes $10Million to restart an Australian Gold Mine.

Where
Australia
Year
2023

More by AFG Venture Group

More deals in Healthcare

Sell-side advisory

NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.

Where
Spain
Year
2026
Sell-side advisory

Nostos Genomics was sold to Limbus Medical Technologies (varvis®).

Where
Switzerland
Year
2025

More Healthcare

Membership

Gain worldwide reach with CapFive M&A professionals

The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.

Become a member

Get in touch

Find an adviser.

Contact us